Complementary and alternative medicine use among women at increased genetic risk of breast and ovarian cancer (Q36667556)

15 August 2017

Complementary and alternative medicine use among women at increased genetic risk of breast and ovarian cancer (English)

1 reference

15 August 2017

1 reference

Christine M Mueller

1

1 reference

15 August 2017

Phuong L Mai

2

1 reference

15 August 2017

Jaime Bucher

3

1 reference

15 August 2017

June A Peters

4

1 reference

15 August 2017

Jennifer T Loud

5

1 reference

15 August 2017

Mark H Greene

6

1 reference

15 August 2017

30 April 2008

1 reference

BMC Complementary and Alternative Medicine

15 August 2017

1 reference

15 August 2017

8

1 reference

15 August 2017

17

1 reference

Creative Commons Attribution 2.0 Generic

15 August 2017

start time

30 April 2008

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Complementary and alternative medicine use among breast cancer survivors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2391138

Trends in complementary/alternative medicine use by breast cancer survivors: comparing survey data from 1998 and 2005

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2391138

Missing data on the Center for Epidemiologic Studies Depression Scale: a comparison of 4 imputation techniques

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2391138

Breast cancer patients' perspectives on and use of complementary and alternative medicine: a study by the Susan G. Komen Breast Cancer Foundation.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2391138

The use of complementary and alternative medicines among patients with locally advanced breast cancer--a descriptive study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2391138

Prevention and management of hereditary breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2391138

Complementary and alternative medicine use among adults: United States, 2002

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2391138

Safety issues in using complementary and alternative medicine

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2391138

Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2391138

Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2391138

Use of alternative therapies for menopause symptoms: results of a population-based survey.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2391138

Prevalence and treatment of menopausal symptoms among breast cancer survivors

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2391138

Alternative therapies used by women with breast cancer in four ethnic populations

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2391138

Psychological side effects of breast cancer screening.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2391138

Complementary and alternative medicine use among American women: findings from The National Health Interview Survey, 2002.

28 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6882-8-17

Use of complementary and alternative medicine and prayer among a national sample of cancer survivors compared to other populations without cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6882-8-17

A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6882-8-17

Complementary and alternative medicine use is associated with an increased perception of breast cancer risk and death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6882-8-17

Depression and the use of complementary medicine among breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6882-8-17

Attitudes to prophylactic surgery and chemoprevention in Australian women at increased risk for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6882-8-17

The CES-D Scale: A Self-Report Depression Scale for Research in the General Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6882-8-17

Use of complimentary and alternative medicine by breast cancer patients: prevalence, patterns and communication with physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6882-8-17

Complementary medicine use among women enrolled in a genetic testing program

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2391138

Use of complementary medicine by adult patients participating in cancer clinical trials.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2391138

Complementary Medicine Use before and 1 Year Following Genetic Testing for BRCA1/2 Mutations

20 September 2018

1 reference

12 December 2020

Behavioral risk factors among women presenting for genetic testing

1 reference

12 December 2020

Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing

1 reference

12 December 2020

Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1/BRCA2 mutation testing

1 reference

12 December 2020

Attitudes about genetic testing for breast-ovarian cancer susceptibility

1 reference

12 December 2020

Attitudes toward prophylactic oophorectomy and screening utilization in women at increased risk of developing hereditary breast/ovarian cancer

1 reference

12 December 2020

Identifiers

DOI

10.1186/1472-6882-8-17

1 reference

Dimensions Publication ID

15 August 2017

0 references

1 reference

15 August 2017

PubMed publication ID

18447953

1 reference